Involvement of brain cytokines in the neurobehavioral disturbances induced by HIV-1 glycoprotein120

Ohr Barak; Inbal Goshen; Tamir Ben-Hur; Joseph Weidenfeld; Anna N. Taylor; Raz Yirmiya

doi:10.1016/S0006-8993(02)02280-1

Involvement of brain cytokines in the neurobehavioral disturbances induced by HIV-1 glycoprotein120

Ohr Barak, Inbal Goshen, Tamir Ben-Hur, Joseph Weidenfeld, Anna N. Taylor, Raz Yirmiya^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

47 Scopus citations

Abstract

Intracerebroventricular (i.c.v.) administration of HIV-1 glycoprotein 120 (gp120), the envelope protein used by the virus to gain access into immune cells, induces neurobehavioral alterations in rats. To examine the role of proinflammatory cytokines in mediating these effects, we measured the effects of gp120 on brain proinflammatory cytokine expression and the effects of anti-inflammatory agents, including interleukin-1 receptor antagonist (IL-1ra), pentoxifylline (a TNFα synthesis blocker) and IL-10, on gp120-induced sickness behavior. I.c.v. administration of gp120 induced the expression of IL-1β, but not TNFα, mRNA in the hypothalamus, 3 h after the injection. Pretreatment of rats with IL-1ra, but not with pentoxifylline, significantly attenuated gp120-induced anorexia and loss in body weight, whereas both agents had no effect on gp120-induced reduction in locomotor activity in the open field. Pretreatment with either IL-1ra and pentoxifylline simultaneously, or with IL-10, produced effects that were similar to the effects of IL-1ra alone. Together, these findings indicate that IL-1, but not TNFα, mediates some of the behavioral effects of acute gp120 administration, suggesting that brain IL-1 may be involved in some of the neurobehavioral abnormalities evident in AIDS patients.

Original language	English
Pages (from-to)	98-108
Number of pages	11
Journal	Brain Research
Volume	933
Issue number	2
DOIs	https://doi.org/10.1016/S0006-8993(02)02280-1
State	Published - 19 Apr 2002

Bibliographical note

Funding Information:
The authors thank Edna Cohen, Anna Itzik, Shiri Lavi, Nadav Mishaan, and Einav Orion and for their assistance in conducting the experiments. IL-1ra was generously provided by Amgen, Thousand Oaks, CA, USA. Recombinant rat IL-10 was generously provided by Dr. Stephen Poole. RrIL-10 was produced within the context of the Biomed Concert Action Cytokines in the Brain. R.Y. is a member of the Eric Roland Center for Neurodegenerative Diseases of The Hebrew University of Jerusalem. This work was supported by a grant 97-204 from the US–Israel Binational Science Foundation.

Keywords

AIDS
Gp120
IL-1
IL-10
Sickness behavior
TNFα

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0006-8993(02)02280-1

Cite this

@article{ef223a912c624feab5125dce5f7b7d27,

title = "Involvement of brain cytokines in the neurobehavioral disturbances induced by HIV-1 glycoprotein120",

abstract = "Intracerebroventricular (i.c.v.) administration of HIV-1 glycoprotein 120 (gp120), the envelope protein used by the virus to gain access into immune cells, induces neurobehavioral alterations in rats. To examine the role of proinflammatory cytokines in mediating these effects, we measured the effects of gp120 on brain proinflammatory cytokine expression and the effects of anti-inflammatory agents, including interleukin-1 receptor antagonist (IL-1ra), pentoxifylline (a TNFα synthesis blocker) and IL-10, on gp120-induced sickness behavior. I.c.v. administration of gp120 induced the expression of IL-1β, but not TNFα, mRNA in the hypothalamus, 3 h after the injection. Pretreatment of rats with IL-1ra, but not with pentoxifylline, significantly attenuated gp120-induced anorexia and loss in body weight, whereas both agents had no effect on gp120-induced reduction in locomotor activity in the open field. Pretreatment with either IL-1ra and pentoxifylline simultaneously, or with IL-10, produced effects that were similar to the effects of IL-1ra alone. Together, these findings indicate that IL-1, but not TNFα, mediates some of the behavioral effects of acute gp120 administration, suggesting that brain IL-1 may be involved in some of the neurobehavioral abnormalities evident in AIDS patients.",

keywords = "AIDS, Gp120, IL-1, IL-10, Sickness behavior, TNFα",

author = "Ohr Barak and Inbal Goshen and Tamir Ben-Hur and Joseph Weidenfeld and Taylor, {Anna N.} and Raz Yirmiya",

note = "Funding Information: The authors thank Edna Cohen, Anna Itzik, Shiri Lavi, Nadav Mishaan, and Einav Orion and for their assistance in conducting the experiments. IL-1ra was generously provided by Amgen, Thousand Oaks, CA, USA. Recombinant rat IL-10 was generously provided by Dr. Stephen Poole. RrIL-10 was produced within the context of the Biomed Concert Action Cytokines in the Brain. R.Y. is a member of the Eric Roland Center for Neurodegenerative Diseases of The Hebrew University of Jerusalem. This work was supported by a grant 97-204 from the US–Israel Binational Science Foundation. ",

year = "2002",

month = apr,

day = "19",

doi = "10.1016/S0006-8993(02)02280-1",

language = "אנגלית",

volume = "933",

pages = "98--108",

journal = "Brain Research",

issn = "0006-8993",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Involvement of brain cytokines in the neurobehavioral disturbances induced by HIV-1 glycoprotein120

AU - Barak, Ohr

AU - Goshen, Inbal

AU - Ben-Hur, Tamir

AU - Weidenfeld, Joseph

AU - Taylor, Anna N.

AU - Yirmiya, Raz

N1 - Funding Information: The authors thank Edna Cohen, Anna Itzik, Shiri Lavi, Nadav Mishaan, and Einav Orion and for their assistance in conducting the experiments. IL-1ra was generously provided by Amgen, Thousand Oaks, CA, USA. Recombinant rat IL-10 was generously provided by Dr. Stephen Poole. RrIL-10 was produced within the context of the Biomed Concert Action Cytokines in the Brain. R.Y. is a member of the Eric Roland Center for Neurodegenerative Diseases of The Hebrew University of Jerusalem. This work was supported by a grant 97-204 from the US–Israel Binational Science Foundation.

PY - 2002/4/19

Y1 - 2002/4/19

N2 - Intracerebroventricular (i.c.v.) administration of HIV-1 glycoprotein 120 (gp120), the envelope protein used by the virus to gain access into immune cells, induces neurobehavioral alterations in rats. To examine the role of proinflammatory cytokines in mediating these effects, we measured the effects of gp120 on brain proinflammatory cytokine expression and the effects of anti-inflammatory agents, including interleukin-1 receptor antagonist (IL-1ra), pentoxifylline (a TNFα synthesis blocker) and IL-10, on gp120-induced sickness behavior. I.c.v. administration of gp120 induced the expression of IL-1β, but not TNFα, mRNA in the hypothalamus, 3 h after the injection. Pretreatment of rats with IL-1ra, but not with pentoxifylline, significantly attenuated gp120-induced anorexia and loss in body weight, whereas both agents had no effect on gp120-induced reduction in locomotor activity in the open field. Pretreatment with either IL-1ra and pentoxifylline simultaneously, or with IL-10, produced effects that were similar to the effects of IL-1ra alone. Together, these findings indicate that IL-1, but not TNFα, mediates some of the behavioral effects of acute gp120 administration, suggesting that brain IL-1 may be involved in some of the neurobehavioral abnormalities evident in AIDS patients.

AB - Intracerebroventricular (i.c.v.) administration of HIV-1 glycoprotein 120 (gp120), the envelope protein used by the virus to gain access into immune cells, induces neurobehavioral alterations in rats. To examine the role of proinflammatory cytokines in mediating these effects, we measured the effects of gp120 on brain proinflammatory cytokine expression and the effects of anti-inflammatory agents, including interleukin-1 receptor antagonist (IL-1ra), pentoxifylline (a TNFα synthesis blocker) and IL-10, on gp120-induced sickness behavior. I.c.v. administration of gp120 induced the expression of IL-1β, but not TNFα, mRNA in the hypothalamus, 3 h after the injection. Pretreatment of rats with IL-1ra, but not with pentoxifylline, significantly attenuated gp120-induced anorexia and loss in body weight, whereas both agents had no effect on gp120-induced reduction in locomotor activity in the open field. Pretreatment with either IL-1ra and pentoxifylline simultaneously, or with IL-10, produced effects that were similar to the effects of IL-1ra alone. Together, these findings indicate that IL-1, but not TNFα, mediates some of the behavioral effects of acute gp120 administration, suggesting that brain IL-1 may be involved in some of the neurobehavioral abnormalities evident in AIDS patients.

KW - AIDS

KW - Gp120

KW - IL-1

KW - IL-10

KW - Sickness behavior

KW - TNFα

UR - http://www.scopus.com/inward/record.url?scp=0037134155&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(02)02280-1

DO - 10.1016/S0006-8993(02)02280-1

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 11931854

AN - SCOPUS:0037134155

SN - 0006-8993

VL - 933

SP - 98

EP - 108

JO - Brain Research

JF - Brain Research

IS - 2

ER -

Involvement of brain cytokines in the neurobehavioral disturbances induced by HIV-1 glycoprotein120

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this